Leff J A, Baer J W, Bodman M E, Kirkman J M, Shanley P F, Patton L M, Beehler C J, McCord J M, Repine J E
Webb-Waring Institute for Biomedical Research, University of Colorado Health Sciences Center, Denver 80262.
Am J Physiol. 1994 Jan;266(1 Pt 1):L2-8. doi: 10.1152/ajplung.1994.266.1.L2.
We found that intratracheal administration of recombinant interleukin-1 alpha (IL-1) into rats rapidly (< 5 h) increased neutrophils in lung lavages and caused an acute edematous lung injury which was reflected by lung albumin accumulation (lung leak) and histological abnormalities (perivascular cuffing). These IL-1-dependent processes were inhibited by prior administration of recombinant IL-1 receptor antagonist and did not occur following administration of heated IL-1. Several lines of evidence suggested that neutrophil-derived oxygen metabolites contributed to lung leak. First, lung leak did not occur in rats rendered neutropenic by vinblastine treatment 4 days before IL-1 administration but did occur in neutrophil-replete rats given vinblastine 1 day before IL-1 administration and control rats given IL-1. Second, treatment with a hydroxyl radical scavenger, dimethyl sulfoxide (DMSO) or a superoxide anion scavenger, manganese superoxide dismutase, decreased lung leak, lung lavage neutrophils, and histological abnormalities in rats given IL-1 intratracheally. Third, intratracheal IL-1 administration increased lung oxidized glutathione (GSSG) levels and expired H2O2 concentrations, and these two indices of oxidative stress were decreased by dimethyl sulfoxide or manganese superoxide dismutase treatment. We conclude that intratracheal administration of IL-1 increases neutrophils in the lung and causes a neutrophil and oxygen metabolite-dependent acute edematous lung injury.
我们发现,向大鼠气管内注射重组白细胞介素-1α(IL-1)可迅速(<5小时)增加肺灌洗中的中性粒细胞数量,并导致急性肺水肿性肺损伤,这表现为肺白蛋白蓄积(肺渗漏)和组织学异常(血管周围套袖状浸润)。这些依赖IL-1的过程可被预先注射重组IL-1受体拮抗剂所抑制,而加热后的IL-1注射后则不会发生。多条证据表明,中性粒细胞衍生的氧代谢产物导致了肺渗漏。首先,在IL-1注射前4天用长春碱处理使大鼠中性粒细胞减少时,肺渗漏未发生,但在IL-1注射前1天给予长春碱的中性粒细胞充足的大鼠和给予IL-1的对照大鼠中发生了肺渗漏。其次,用羟基自由基清除剂二甲基亚砜(DMSO)或超氧阴离子清除剂锰超氧化物歧化酶处理,可减少气管内给予IL-1的大鼠的肺渗漏、肺灌洗中性粒细胞数量和组织学异常。第三,气管内注射IL-1可增加肺氧化型谷胱甘肽(GSSG)水平和呼出的过氧化氢浓度,而二甲基亚砜或锰超氧化物歧化酶处理可降低这两个氧化应激指标。我们得出结论,气管内注射IL-1可增加肺中的中性粒细胞数量,并导致依赖中性粒细胞和氧代谢产物的急性肺水肿性肺损伤。